Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DG07UD
|
|||
| Drug Name |
VCB102
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Psoriasis vulgaris [ICD-11: EA90; ICD-10: L40] | Preclinical | [1] | |
| Company |
V ClinBio
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cysteines of Keap1 (KEAP1 Cysteines) | Target Info | Inactivator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov. 2019 Apr;18(4):295-317. | |||
| REF 2 | NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases. Biomolecules. 2020 Jun 14;10(6):904. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.